Global Neuromyelitis Optica Drug Market Professional Survey Report 2017

December 2017 | 111 pages | ID: G5D9458DC84EN
QYResearch

Abstracts

This report studies Neuromyelitis Optica Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Pfizer
• FRESENIUS
• TEVA
• SANDOZ
• Intas
• Gyjtrs
• NANG KUANG
• Tianjin Kingyork
• Baxter
• CSL
• Grifols
• Octapharma
• CBOP

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Glucocorticoids
• Immunoglobulin
• Other

By Application, the market can be split into

• Acute Attack
• Remission Prophylactic Treatment

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Neuromyelitis Optica Drug Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF NEUROMYELITIS OPTICA DRUG

1.1 Definition and Specifications of Neuromyelitis Optica Drug
  1.1.1 Definition of Neuromyelitis Optica Drug
  1.1.2 Specifications of Neuromyelitis Optica Drug
1.2 Classification of Neuromyelitis Optica Drug
  1.2.1 Glucocorticoids
  1.2.2 Immunoglobulin
  1.2.3 Other
1.3 Applications of Neuromyelitis Optica Drug
  1.3.1 Acute Attack
  1.3.2 Remission Prophylactic Treatment
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF NEUROMYELITIS OPTICA DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Neuromyelitis Optica Drug
2.3 Manufacturing Process Analysis of Neuromyelitis Optica Drug
2.4 Industry Chain Structure of Neuromyelitis Optica Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF NEUROMYELITIS OPTICA DRUG

3.1 Capacity and Commercial Production Date of Global Neuromyelitis Optica Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Neuromyelitis Optica Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Neuromyelitis Optica Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Neuromyelitis Optica Drug Major Manufacturers in 2016

4 GLOBAL NEUROMYELITIS OPTICA DRUG OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Neuromyelitis Optica Drug Capacity and Growth Rate Analysis
  4.2.2 2016 Neuromyelitis Optica Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Neuromyelitis Optica Drug Sales and Growth Rate Analysis
  4.3.2 2016 Neuromyelitis Optica Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Neuromyelitis Optica Drug Sales Price
  4.4.2 2016 Neuromyelitis Optica Drug Sales Price Analysis (Company Segment)

5 NEUROMYELITIS OPTICA DRUG REGIONAL MARKET ANALYSIS

5.1 North America Neuromyelitis Optica Drug Market Analysis
  5.1.1 North America Neuromyelitis Optica Drug Market Overview
  5.1.2 North America 2012-2017E Neuromyelitis Optica Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Neuromyelitis Optica Drug Sales Price Analysis
  5.1.4 North America 2016 Neuromyelitis Optica Drug Market Share Analysis
5.2 China Neuromyelitis Optica Drug Market Analysis
  5.2.1 China Neuromyelitis Optica Drug Market Overview
  5.2.2 China 2012-2017E Neuromyelitis Optica Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Neuromyelitis Optica Drug Sales Price Analysis
  5.2.4 China 2016 Neuromyelitis Optica Drug Market Share Analysis
5.3 Europe Neuromyelitis Optica Drug Market Analysis
  5.3.1 Europe Neuromyelitis Optica Drug Market Overview
  5.3.2 Europe 2012-2017E Neuromyelitis Optica Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Neuromyelitis Optica Drug Sales Price Analysis
  5.3.4 Europe 2016 Neuromyelitis Optica Drug Market Share Analysis
5.4 Southeast Asia Neuromyelitis Optica Drug Market Analysis
  5.4.1 Southeast Asia Neuromyelitis Optica Drug Market Overview
  5.4.2 Southeast Asia 2012-2017E Neuromyelitis Optica Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Neuromyelitis Optica Drug Sales Price Analysis
  5.4.4 Southeast Asia 2016 Neuromyelitis Optica Drug Market Share Analysis
5.5 Japan Neuromyelitis Optica Drug Market Analysis
  5.5.1 Japan Neuromyelitis Optica Drug Market Overview
  5.5.2 Japan 2012-2017E Neuromyelitis Optica Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Neuromyelitis Optica Drug Sales Price Analysis
  5.5.4 Japan 2016 Neuromyelitis Optica Drug Market Share Analysis
5.6 India Neuromyelitis Optica Drug Market Analysis
  5.6.1 India Neuromyelitis Optica Drug Market Overview
  5.6.2 India 2012-2017E Neuromyelitis Optica Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Neuromyelitis Optica Drug Sales Price Analysis
  5.6.4 India 2016 Neuromyelitis Optica Drug Market Share Analysis

6 GLOBAL 2012-2017E NEUROMYELITIS OPTICA DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Neuromyelitis Optica Drug Sales by Type
6.2 Different Types of Neuromyelitis Optica Drug Product Interview Price Analysis
6.3 Different Types of Neuromyelitis Optica Drug Product Driving Factors Analysis
  6.3.1 Glucocorticoids of Neuromyelitis Optica Drug Growth Driving Factor Analysis
  6.3.2 Immunoglobulin of Neuromyelitis Optica Drug Growth Driving Factor Analysis
  6.3.3 Other of Neuromyelitis Optica Drug Growth Driving Factor Analysis

7 GLOBAL 2012-2017E NEUROMYELITIS OPTICA DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Neuromyelitis Optica Drug Consumption by Application
7.2 Different Application of Neuromyelitis Optica Drug Product Interview Price Analysis
7.3 Different Application of Neuromyelitis Optica Drug Product Driving Factors Analysis
  7.3.1 Acute Attack of Neuromyelitis Optica Drug Growth Driving Factor Analysis
  7.3.2 Remission Prophylactic Treatment of Neuromyelitis Optica Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF NEUROMYELITIS OPTICA DRUG

8.1 Pfizer
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Pfizer 2016 Neuromyelitis Optica Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Pfizer 2016 Neuromyelitis Optica Drug Business Region Distribution Analysis
8.2 FRESENIUS
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 FRESENIUS 2016 Neuromyelitis Optica Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 FRESENIUS 2016 Neuromyelitis Optica Drug Business Region Distribution Analysis
8.3 TEVA
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 TEVA 2016 Neuromyelitis Optica Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 TEVA 2016 Neuromyelitis Optica Drug Business Region Distribution Analysis
8.4 SANDOZ
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 SANDOZ 2016 Neuromyelitis Optica Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 SANDOZ 2016 Neuromyelitis Optica Drug Business Region Distribution Analysis
8.5 Intas
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Intas 2016 Neuromyelitis Optica Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Intas 2016 Neuromyelitis Optica Drug Business Region Distribution Analysis
8.6 Gyjtrs
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Gyjtrs 2016 Neuromyelitis Optica Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Gyjtrs 2016 Neuromyelitis Optica Drug Business Region Distribution Analysis
8.7 NANG KUANG
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 NANG KUANG 2016 Neuromyelitis Optica Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 NANG KUANG 2016 Neuromyelitis Optica Drug Business Region Distribution Analysis
8.8 Tianjin Kingyork
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Tianjin Kingyork 2016 Neuromyelitis Optica Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Tianjin Kingyork 2016 Neuromyelitis Optica Drug Business Region Distribution Analysis
8.9 Baxter
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Baxter 2016 Neuromyelitis Optica Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Baxter 2016 Neuromyelitis Optica Drug Business Region Distribution Analysis
8.10 CSL
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 CSL 2016 Neuromyelitis Optica Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 CSL 2016 Neuromyelitis Optica Drug Business Region Distribution Analysis
8.11 Grifols
8.12 Octapharma
8.13 CBOP

9 DEVELOPMENT TREND OF ANALYSIS OF NEUROMYELITIS OPTICA DRUG MARKET

9.1 Global Neuromyelitis Optica Drug Market Trend Analysis
  9.1.1 Global 2017-2022 Neuromyelitis Optica Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Neuromyelitis Optica Drug Sales Price Forecast
9.2 Neuromyelitis Optica Drug Regional Market Trend
  9.2.1 North America 2017-2022 Neuromyelitis Optica Drug Consumption Forecast
  9.2.2 China 2017-2022 Neuromyelitis Optica Drug Consumption Forecast
  9.2.3 Europe 2017-2022 Neuromyelitis Optica Drug Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Neuromyelitis Optica Drug Consumption Forecast
  9.2.5 Japan 2017-2022 Neuromyelitis Optica Drug Consumption Forecast
  9.2.6 India 2017-2022 Neuromyelitis Optica Drug Consumption Forecast
9.3 Neuromyelitis Optica Drug Market Trend (Product Type)
9.4 Neuromyelitis Optica Drug Market Trend (Application)

10 NEUROMYELITIS OPTICA DRUG MARKETING TYPE ANALYSIS

10.1 Neuromyelitis Optica Drug Regional Marketing Type Analysis
10.2 Neuromyelitis Optica Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Neuromyelitis Optica Drug by Region
10.4 Neuromyelitis Optica Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF NEUROMYELITIS OPTICA DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL NEUROMYELITIS OPTICA DRUG MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neuromyelitis Optica Drug
Table Product Specifications of Neuromyelitis Optica Drug
Table Classification of Neuromyelitis Optica Drug
Figure Global Production Market Share of Neuromyelitis Optica Drug by Type in 2016
Figure Glucocorticoids Picture
Table Major Manufacturers of Glucocorticoids
Figure Immunoglobulin Picture
Table Major Manufacturers of Immunoglobulin
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Neuromyelitis Optica Drug
Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Application in 2016
Figure Acute Attack Examples
Table Major Consumers in Acute Attack
Figure Remission Prophylactic Treatment Examples
Table Major Consumers in Remission Prophylactic Treatment
Figure Market Share of Neuromyelitis Optica Drug by Regions
Figure North America Neuromyelitis Optica Drug Market Size (Million USD) (2012-2022)
Figure China Neuromyelitis Optica Drug Market Size (Million USD) (2012-2022)
Figure Europe Neuromyelitis Optica Drug Market Size (Million USD) (2012-2022)
Figure Southeast Asia Neuromyelitis Optica Drug Market Size (Million USD) (2012-2022)
Figure Japan Neuromyelitis Optica Drug Market Size (Million USD) (2012-2022)
Figure India Neuromyelitis Optica Drug Market Size (Million USD) (2012-2022)
Table Neuromyelitis Optica Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Neuromyelitis Optica Drug in 2016
Figure Manufacturing Process Analysis of Neuromyelitis Optica Drug
Figure Industry Chain Structure of Neuromyelitis Optica Drug
Table Capacity and Commercial Production Date of Global Neuromyelitis Optica Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Neuromyelitis Optica Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Neuromyelitis Optica Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Neuromyelitis Optica Drug Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Neuromyelitis Optica Drug 2012-2017
Figure Global 2012-2017E Neuromyelitis Optica Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Neuromyelitis Optica Drug Market Size (Value) and Growth Rate
Table 2012-2017E Global Neuromyelitis Optica Drug Capacity and Growth Rate
Table 2016 Global Neuromyelitis Optica Drug Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Neuromyelitis Optica Drug Sales (K Units) and Growth Rate
Table 2016 Global Neuromyelitis Optica Drug Sales (K Units) List (Company Segment)
Table 2012-2017E Global Neuromyelitis Optica Drug Sales Price (USD/Unit)
Table 2016 Global Neuromyelitis Optica Drug Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Neuromyelitis Optica Drug 2012-2017E
Figure North America 2012-2017E Neuromyelitis Optica Drug Sales Price (USD/Unit)
Figure North America 2016 Neuromyelitis Optica Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Neuromyelitis Optica Drug 2012-2017E
Figure China 2012-2017E Neuromyelitis Optica Drug Sales Price (USD/Unit)
Figure China 2016 Neuromyelitis Optica Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Neuromyelitis Optica Drug 2012-2017E
Figure Europe 2012-2017E Neuromyelitis Optica Drug Sales Price (USD/Unit)
Figure Europe 2016 Neuromyelitis Optica Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Neuromyelitis Optica Drug 2012-2017E
Figure Southeast Asia 2012-2017E Neuromyelitis Optica Drug Sales Price (USD/Unit)
Figure Southeast Asia 2016 Neuromyelitis Optica Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Neuromyelitis Optica Drug 2012-2017E
Figure Japan 2012-2017E Neuromyelitis Optica Drug Sales Price (USD/Unit)
Figure Japan 2016 Neuromyelitis Optica Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Neuromyelitis Optica Drug 2012-2017E
Figure India 2012-2017E Neuromyelitis Optica Drug Sales Price (USD/Unit)
Figure India 2016 Neuromyelitis Optica Drug Sales Market Share
Table Global 2012-2017E Neuromyelitis Optica Drug Sales (K Units) by Type
Table Different Types Neuromyelitis Optica Drug Product Interview Price
Table Global 2012-2017E Neuromyelitis Optica Drug Sales (K Units) by Application
Table Different Application Neuromyelitis Optica Drug Product Interview Price
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Neuromyelitis Optica Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer Neuromyelitis Optica Drug Business Region Distribution
Table FRESENIUS Information List
Table Product A Overview
Table Product B Overview
Table 2016 FRESENIUS Neuromyelitis Optica Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 FRESENIUS Neuromyelitis Optica Drug Business Region Distribution
Table TEVA Information List
Table Product A Overview
Table Product B Overview
Table 2015 TEVA Neuromyelitis Optica Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 TEVA Neuromyelitis Optica Drug Business Region Distribution
Table SANDOZ Information List
Table Product A Overview
Table Product B Overview
Table 2016 SANDOZ Neuromyelitis Optica Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 SANDOZ Neuromyelitis Optica Drug Business Region Distribution
Table Intas Information List
Table Product A Overview
Table Product B Overview
Table 2016 Intas Neuromyelitis Optica Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Intas Neuromyelitis Optica Drug Business Region Distribution
Table Gyjtrs Information List
Table Product A Overview
Table Product B Overview
Table 2016 Gyjtrs Neuromyelitis Optica Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Gyjtrs Neuromyelitis Optica Drug Business Region Distribution
Table NANG KUANG Information List
Table Product A Overview
Table Product B Overview
Table 2016 NANG KUANG Neuromyelitis Optica Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 NANG KUANG Neuromyelitis Optica Drug Business Region Distribution
Table Tianjin Kingyork Information List
Table Product A Overview
Table Product B Overview
Table 2016 Tianjin Kingyork Neuromyelitis Optica Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Tianjin Kingyork Neuromyelitis Optica Drug Business Region Distribution
Table Baxter Information List
Table Product A Overview
Table Product B Overview
Table 2016 Baxter Neuromyelitis Optica Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Baxter Neuromyelitis Optica Drug Business Region Distribution
Table CSL Information List
Table Product A Overview
Table Product B Overview
Table 2016 CSL Neuromyelitis Optica Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 CSL Neuromyelitis Optica Drug Business Region Distribution
Table Grifols Information List
Table Octapharma Information List
Table CBOP Information List
Figure Global 2017-2022 Neuromyelitis Optica Drug Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Neuromyelitis Optica Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Neuromyelitis Optica Drug Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Neuromyelitis Optica Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Neuromyelitis Optica Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Neuromyelitis Optica Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Neuromyelitis Optica Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Neuromyelitis Optica Drug Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Neuromyelitis Optica Drug Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Neuromyelitis Optica Drug by Type 2017-2022
Table Global Consumption Volume (K Units) of Neuromyelitis Optica Drug by Application 2017-2022
Table Traders or Distributors with Contact Information of Neuromyelitis Optica Drug by Region